What is the best management approach for a 5-year-old female patient presenting with impaired renal function, electrolyte imbalance, hypotension, tachycardia, tachypnea, and abnormal urinalysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Acute Kidney Injury with Severe Electrolyte Disturbances in a 5-Year-Old

This child requires immediate hospitalization with urgent nephrology consultation and aggressive supportive care for acute kidney injury with severe hyponatremia, hypovolemic shock, and likely nephrotic syndrome. 1, 2

Immediate eGFR Calculation and Interpretation

Using the Schwartz formula for pediatric eGFR: eGFR = (k × height in cm) / serum creatinine (mg/dL), where k = 0.413 for children aged 1-12 years 3

  • Converting creatinine: 401.45 μmol/L = 4.54 mg/dL
  • Assuming average height for 5-year-old female (~110 cm): eGFR ≈ 10 mL/min/1.73m² 3
  • This represents severe kidney dysfunction (KDIGO stage G5) 1
  • The BUN/Cr ratio of 74 mmol/L ÷ 4.54 mg/dL = 16.3, which is within normal range, suggesting intrinsic renal disease rather than prerenal azotemia 4, 5

Critical Initial Assessment and Stabilization

The combination of hypotension (93/33 mmHg), tachycardia (168/min), tachypnea (45/min), and severe hyponatremia (121.8 mmol/L) indicates hypovolemic shock requiring immediate intervention 1, 2

Volume Status Assessment

  • Clinical indicators of hypovolemia are present: hypotension, tachycardia, and likely oliguria given the severe AKI 1, 2
  • The 3+ proteinuria with specific gravity 1.010 suggests nephrotic-range proteinuria with loss of concentrating ability 1, 6
  • Administer 20% albumin infusion (0.5-1 g/kg over 2-4 hours) followed by furosemide (1-2 mg/kg IV) at the end of infusion to enhance diuresis and restore intravascular volume 1, 2

Severe Hyponatremia Management

  • The sodium of 121.8 mmol/L with neurological risk (tachypnea may indicate compensatory response) requires cautious correction 1
  • Correct sodium at maximum 10-12 mmol/L per 24 hours to avoid osmotic demyelination syndrome 1
  • Use 3% hypertonic saline only if symptomatic (seizures, altered mental status), otherwise correct with albumin infusion and fluid restriction 1

Diagnostic Workup

The urinalysis showing turbid, dark urine with 3+ protein strongly suggests nephrotic syndrome, though the presentation includes nephritic features 1, 2, 6

Essential Laboratory Studies

  • Spot urine protein-to-creatinine ratio to quantify proteinuria (likely >2 g/g given 3+ dipstick) 1, 2
  • Serum albumin, total protein, lipid panel to confirm nephrotic syndrome 1, 2
  • Complete blood count with differential, inflammatory markers (ESR, CRP) 1
  • Complement levels (C3, C4), ANA, anti-dsDNA, ANCA panel to evaluate for secondary causes 6
  • Hepatitis B, C, HIV screening given the proteinuria 1
  • Urine microscopy for RBC casts (suggests nephritic component) 6

Imaging

  • Renal ultrasound with Doppler to assess kidney size, echogenicity, rule out obstruction, and evaluate for renal vein thrombosis (complication of nephrotic syndrome) 1

Ongoing Management Strategy

Fluid and Electrolyte Management

  • Strict fluid restriction to insensible losses plus urine output (approximately 400-600 mL/m²/day) 1, 2
  • Avoid intravenous saline; concentrate oral fluids 1
  • Monitor serum electrolytes every 6-12 hours initially, then daily once stable 1
  • Potassium is currently normal (3.67 mmol/L) but requires close monitoring as it may rise with worsening AKI 1

Diuretic Therapy

  • After volume resuscitation with albumin, initiate furosemide 1-2 mg/kg IV every 6-12 hours 1
  • If inadequate response, consider sequential nephron blockade with addition of metolazone 0.1-0.2 mg/kg/dose once daily 1
  • Monitor for hypokalemia with aggressive diuresis, though current potassium is acceptable 1

Blood Pressure Management

  • Current BP (93/33 mmHg) is hypotensive for age; once euvolemia achieved, reassess for hypertension typical of nephritic syndrome 6
  • If hypertension develops after volume restoration, initiate ACE inhibitor (enalapril 0.08 mg/kg/day) for both BP control and antiproteinuric effect 1

Renal Replacement Therapy Considerations

  • With eGFR ~10 mL/min/1.73m² and clinical instability, prepare for potential dialysis if: 1
    • Severe hyperkalemia develops (>6.5 mmol/L)
    • Refractory fluid overload with pulmonary edema
    • Symptomatic uremia (pericarditis, encephalopathy)
    • Inability to correct severe hyponatremia safely
    • Severe metabolic acidosis (pH <7.1)

Nephrology Consultation and Definitive Diagnosis

Urgent pediatric nephrology consultation is mandatory given the severity of presentation and need for potential kidney biopsy 1, 2

Biopsy Considerations

  • Kidney biopsy should be strongly considered once hemodynamically stable and coagulation parameters acceptable to determine underlying etiology 1, 2
  • The combination of severe proteinuria, AKI, and young age raises concern for congenital nephrotic syndrome, focal segmental glomerulosclerosis, or minimal change disease with acute tubular necrosis 1, 2
  • Biopsy is particularly important given the severity and to guide immunosuppressive therapy decisions 2

Genetic Testing

  • Send genetic panel for congenital nephrotic syndrome genes (NPHS1, NPHS2, WT1, LAMB2) given age and severity 1

Infection Prophylaxis and Complications

Children with nephrotic syndrome and severe hypoalbuminemia are at high risk for bacterial infections, particularly spontaneous bacterial peritonitis and sepsis 1

  • Consider prophylactic antibiotics if albumin <2 g/dL and peritoneal signs develop 1
  • Avoid central venous lines if possible due to thrombosis risk; if required, provide prophylactic anticoagulation 1
  • Monitor for signs of infection at every clinical contact 1

Monitoring Parameters

Given KDIGO stage G5 CKD, laboratory monitoring should occur every 1-3 months once stabilized 1

  • Serum electrolytes, BUN, creatinine 1
  • Acid-base status (venous blood gas or total CO₂) 1
  • Calcium, phosphate, PTH, 25-OH vitamin D 1
  • Hemoglobin and iron studies 1
  • Spot urine protein-to-creatinine ratio 1, 2

Critical Pitfalls to Avoid

  • Do not rely on serum creatinine alone in children; always calculate eGFR using age-appropriate formulas 3, 4
  • Do not administer albumin based solely on low levels; only give for clinical hypovolemia 1, 2
  • Do not correct severe hyponatremia too rapidly (>10-12 mmol/L per 24 hours) 1
  • Do not assume nephrotic syndrome alone; the severe AKI and mixed picture require biopsy for definitive diagnosis 1, 2, 6
  • Do not delay nephrology referral; this child requires subspecialty management immediately 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Frequent Relapse Nephrotic Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation of renal function during childhood.

Pediatrics in review, 1996

Research

Assessment of renal function from plasma urea and plasma creatinine in children.

Scandinavian journal of urology and nephrology, 1982

Research

Uremia with low serum creatinine-an entity produced by marked creatinine secretion.

The American journal of the medical sciences, 1977

Guideline

Clinical Manifestations and Management of Nephritic Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.